Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2011 - 2026)
Oramed Pharmaceuticals (ORMP) reported Exchange Rate Effect of $22000.0 for Q1 2026, up 2300.0% on a YoY basis from $916.67 in Q1 2025, and up 130.14% quarter-over-quarter from -$73000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Exchange Rate Effect for 16 years, with the latest figure at $22000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 2300.0% year-over-year to $22000.0; the trailing twelve-month figure through Mar 2026 stood at -$7000.0 (down 75.0% YoY), and the FY2025 full-year result was -$30000.0, down 650.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $22000.0, up from -$73000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $40000.0 in Q2 2025, with the low at -$105000.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged -$9562.5 across 5 years, with a median of $1000.0 in 2022.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect tumbled 3550.0% — and 2026, when it soared 2300.0%.
- Oramed Pharmaceuticals' Exchange Rate Effect stood at -$105000.0 in 2022, then surged by 107.62% to $8000.0 in 2023, then tumbled by 125.0% to -$2000.0 in 2024, then plunged by 3550.0% to -$73000.0 in 2025, then jumped by 130.14% to $22000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $22000.0 (Q1 2026), -$73000.0 (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - | 22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |